Reprinted from February 2019Supported by Management of NAFLD: Use of a New Therapeutic Approach to Reduce Risk Factors Introduction Non-alcoholic fatty liver disease (NAFLD) is a slowly progressive condition affecting 30% of the total US population, and is strongly linked to obesity.1 NAFLD is defined as steatosis affecting at least 5% of liver volume or weight in the absence of significant alcohol consumption, or an excessive accumulation of fat in the liver with more than 5% of hepatocytes
FEBRUARY 11, 2019